Announcement of the company's individual financial report for Q2 22 has been approved by the board of directors.
· Issued by EPS Bio Technology Corp.
Close
Today's Information
Provided by: EPS Bio Technology Corp.
SEQ_NO
2
Date of announcement
2022/08/04
Time of announcement
16:24:43
Subject
Announcement of the company's individual
financial report for Q2 22 has been approved by
the board of directors.
Date of events
2022/08/04
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/08/04
2.Date of the audit committee approved:2022/08/04
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):213,058
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):49,083
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):3,435
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):9,510
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):7,459
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):7,459
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):0.31
11.Total assets end of the period (thousand NTD):580,837
12.Total liabilities end of the period
(thousand NTD):290,765
13.Equity attributable to owners of parent end of the
period (thousand NTD):290,072
14.Any other matters that need to be specified:None
